Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shreenath Chemicals is an Indian pharmaceutical company specializing in the manufacture and export of Active Pharmaceutical Ingredients (APIs) and bulk drug intermediates. Established in 1992 and headquartered in Navi Mumbai, the company is a leading producer of Cinchona alkaloids, including various salts of Quinine and Quinidine. Their product portfolio serves global markets for the treatment of malaria, cardiac arrhythmias, and muscle cramps. Operating out of a GMP-compliant facility in Ambernath, Maharashtra, Shreenath Chemicals provides high-quality chemical synthesis and extraction services to the global pharmaceutical industry. The company is recognized for its commitment to international quality standards and its role as a key supplier of niche alkaloid-based compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shreenath Chemicals.